Wednesday, September 23, 2015

Scientific and industrial challenges of developing nanoparticle-based theranostics and multiple-modality contrast agents for clinical application

Nanoscale, 2015, Advance Article
DOI: 10.1039/C5NR03887A, Opinion
Yi Xiang J. Wang, Jean-Marc Idee, Claire Corot
To select the best nanoparticle candidate for clinical translation, several key-issues must be considered early, both at the research (left) and marketing (right) levels. The radar graph may serve an evaluation tool. The weighing of the individual criterion is crucial.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment